USFDA gives nod to this Nasal spray for Vitamin B12 deficiency

Cyanocobalamin is a form of vitamin B12 used to treat vitamin B12 deficiency.

238
USFDA Drug product Approval
USFDA Approval

Last Updated on December 31, 2023 by The Health Master

Global pharma major Lupin Limited announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Cyanocobalamin Nasal Spray, 500 mcg/spray (One Spray per Device).

According to the company’s press statement, it is a generic equivalent of Nascobal Nasal Spray, 500 mcg/spray of Par Pharmaceutical, Inc.

This product will be manufactured at Lupin’s Somerset facility in the United States.

Cyanocobalamin is a form of vitamin B12 used to treat vitamin B12 deficiency.

Cyanocobalamin Nasal Spray (RLD Nascobal) had estimated annual sales of USD 69 million in the U.S. (IQVIA MAT Mar 2023).

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news